PT94037A - Processo para a preparacao de factor de crescimento epidermico (epidermal growth factor) e de composicoes farmaceuticas que o contem - Google Patents

Processo para a preparacao de factor de crescimento epidermico (epidermal growth factor) e de composicoes farmaceuticas que o contem

Info

Publication number
PT94037A
PT94037A PT94037A PT9403790A PT94037A PT 94037 A PT94037 A PT 94037A PT 94037 A PT94037 A PT 94037A PT 9403790 A PT9403790 A PT 9403790A PT 94037 A PT94037 A PT 94037A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
growth factor
epidermal growth
preparing epidermal
preparing
Prior art date
Application number
PT94037A
Other languages
English (en)
Other versions
PT94037B (pt
Inventor
John K Cini
Amy L Finkenaur
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of PT94037A publication Critical patent/PT94037A/pt
Publication of PT94037B publication Critical patent/PT94037B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PT94037A 1989-05-16 1990-05-15 Processo para a preparacao de factor de crescimento epidermico (epidermal growth factor) e de composicoes farmaceuticas que o contem PT94037B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/353,131 US5130298A (en) 1989-05-16 1989-05-16 Stabilized compositions containing epidermal growth factor

Publications (2)

Publication Number Publication Date
PT94037A true PT94037A (pt) 1991-01-08
PT94037B PT94037B (pt) 1996-11-29

Family

ID=23387889

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94037A PT94037B (pt) 1989-05-16 1990-05-15 Processo para a preparacao de factor de crescimento epidermico (epidermal growth factor) e de composicoes farmaceuticas que o contem

Country Status (11)

Country Link
US (1) US5130298A (pt)
EP (1) EP0398619B1 (pt)
JP (1) JP2763815B2 (pt)
KR (1) KR900017580A (pt)
AU (1) AU630952B2 (pt)
CA (1) CA2016659C (pt)
DE (1) DE69002795T2 (pt)
DK (1) DK0398619T3 (pt)
ES (1) ES2058799T3 (pt)
GR (1) GR1000392B (pt)
PT (1) PT94037B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326154B1 (en) * 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
WO1993003757A1 (en) * 1991-08-16 1993-03-04 Chiron Corporation Muteins of epidermal growth factor exhibiting enhanced binding at low ph
US5618544A (en) * 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
WO1995022560A1 (en) * 1994-02-22 1995-08-24 The Syntex-Synergen Neuroscience Joint Venture Pharmaceutical formulations of cntf
US6048545A (en) * 1994-06-24 2000-04-11 Biozone Laboratories, Inc. Liposomal delivery by iontophoresis
CN1043732C (zh) * 1994-12-22 1999-06-23 大连医科大学 治疗口腔糜烂面的新型药膜
EP0861089B1 (en) * 1995-11-13 2002-07-17 Medtronic MiniMed, Inc. Methods and compositions for the delivery of monomeric proteins
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
ATE403714T1 (de) 1996-11-06 2008-08-15 Univ California Tumor necrosis factor rezeptor abspaltendes enzym,dessen zubereitungen und verwendungen
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US7033615B2 (en) * 1999-07-09 2006-04-25 Cancer2 Inc. Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US20070087965A1 (en) * 2005-10-03 2007-04-19 Neirinckx Rudi D Treatment of psoriasis through down-regulation of the egf-receptor with topically applied egf
US7015199B1 (en) * 2000-06-02 2006-03-21 Neirinckx Rudi D Treatment of psoriasis through down-regulation of the EGF-receptor with topically-applied EGF
CA2417331C (en) * 2000-07-28 2011-03-22 Christopher J. Murphy Transplant media comprising bnp-1
HK1077740A1 (en) * 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
WO2003075949A1 (en) * 2002-03-12 2003-09-18 Bio-Click Technologies Ltd. Method and composition for treating skin wounds with epidermal growth factor
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
US20050214382A1 (en) * 2004-03-29 2005-09-29 Erning Xia Zinc preservative composition and method of use
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
BRPI0610704B8 (pt) 2005-05-27 2021-05-25 Bharat Biotech Int Ltd composição do fator de crescimento epidérmico, o processo para isso e sua aplicação
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
CU23388B6 (es) * 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
EP2066300B2 (en) * 2006-09-28 2019-01-23 Novartis Ag Self-preserved aqueous pharmaceutical compositions
CU23526B6 (es) * 2006-10-03 2010-05-19 Ct Ingenieria Genetica Biotech Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética
KR100784134B1 (ko) * 2006-10-09 2007-12-12 주식회사 대웅 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물
JP5583111B2 (ja) * 2008-03-17 2014-09-03 アルコン リサーチ， リミテッド ボレート−ポリオール錯体を含有する水性薬学的組成物
JP5303322B2 (ja) * 2009-03-13 2013-10-02 ピアス株式会社 皮膚外用組成物
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
RU2012133444A (ru) * 2010-01-06 2014-02-20 Орф Лифтаекни Хф Способ, применения стабильного фактора роста растительного происхождения в уходе за кожей
US20140005128A1 (en) 2010-08-11 2014-01-02 Forest Laboratories Holdings Limited Treatments of gastrointestinal disorders
JP5798356B2 (ja) * 2011-04-06 2015-10-21 一般財団法人化学及血清療法研究所 新規インフルエンザワクチン安定化剤
SG11201507429TA (en) 2013-03-15 2015-10-29 Genentech Inc Il-22 polypeptides and il-22 fc fusion proteins and methods of use
US9283172B2 (en) 2013-12-13 2016-03-15 Growgene Biotech Inc. Use of stem cell conditioned medium to induce ZO-1 proteins expression for skin regeneration, repair and firming
KR101868966B1 (ko) * 2016-05-12 2018-06-19 주식회사 엔씨엘바이오 열 안정성을 증진시킨 사람 상피세포 성장인자의 조성물
CR20200327A (es) 2018-01-26 2020-11-05 Genentech Inc Proteínas de fusión fc il-22 y métodos de uso
CA3088763A1 (en) 2018-01-26 2019-08-01 Genentech, Inc. Compositions and methods of use
AU2019226085A1 (en) 2018-02-21 2020-09-17 Genentech, Inc. Dosing for treatment with IL-22 Fc fusion proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA972288A (en) * 1971-01-20 1975-08-05 Gyorgy Hajos Process for the preparation of new complexes of biologically active peptides, polypeptides, proteins or derivatives or salts thereof having prolonged and/or increased activity
US3887704A (en) * 1974-03-12 1975-06-03 Joseph Lichtenstein Aqueous zinc solutions for physiological use
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
HU194280B (en) * 1985-10-22 1988-01-28 Richter Gedeon Vegyeszet Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
US4717717A (en) * 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
GR1000392B (el) 1992-06-30
GR900100334A (en) 1991-10-10
DE69002795D1 (de) 1993-09-23
EP0398619A3 (en) 1991-04-03
DE69002795T2 (de) 1994-01-13
ES2058799T3 (es) 1994-11-01
JP2763815B2 (ja) 1998-06-11
EP0398619A2 (en) 1990-11-22
JPH0334992A (ja) 1991-02-14
PT94037B (pt) 1996-11-29
CA2016659A1 (en) 1990-11-16
AU630952B2 (en) 1992-11-12
KR900017580A (ko) 1990-12-19
CA2016659C (en) 1996-12-10
DK0398619T3 (da) 1993-10-04
US5130298A (en) 1992-07-14
EP0398619B1 (en) 1993-08-18
AU5496890A (en) 1990-11-22

Similar Documents

Publication Publication Date Title
PT94037A (pt) Processo para a preparacao de factor de crescimento epidermico (epidermal growth factor) e de composicoes farmaceuticas que o contem
PT93079A (pt) Processo para a preparacao de composicoes farmaceuticas que contem ciclosporinas
PT89009A (pt) Processo para a preparacao de novos derivados de fluorocitidina e composicoes farmaceuticas que os contem
PT84569B (pt) Processo para a preparacao de tiazepinas e de composicoes farmaceuticas que os contem
PT90836A (pt) Processo para a preparacao de derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT81746B (pt) Processo para a preparacao de peptido-aldeidos e de composicoes farmaceuticas que os contem
PT87913A (pt) Processo para a preparacao de derivados de benzopirano e de composicoes farmaceuticas que os contem
PT89899A (pt) Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT92368A (pt) Processo para a preparacao de novas quinuclidinas e de composicoes farmaceuticas que as contem
PT84149B (pt) Processo para a preparacao de novas tieno-1,4-diazepinas e de composicoes farmaceuticas que as contem
PT87201A (pt) Processo para a preparacao de novos derivados de cefalosporina 3,7-substituida e de composicoes farmaceuticas que os contem
PT93600A (pt) Processo para a preparacao de pteridin-4(3h)-onas e de composicoes farmaceuticas que os contem
PT88914A (pt) Processo para a preparacao de polipeptidos e de composicoes farmaceuticas que os contem
PT93060A (pt) Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
PT81659B (pt) Processo para a preparacao de aminoacil-labdanos e de composicoes farmaceuticas que os contem
PT91122A (pt) Processo para a preparacao de novos derivados amidinicos e guanidinicos e de composicoes farmaceuticas que os contem
PT89234A (pt) Processo para a preparacao de novos compostos de amonio e de composicoes farmaceuticas que os contem
PT94902A (pt) Processo para a preparacao de novos derivados de cromano e de composicoes farmaceuticas que os contem
PT93138A (pt) Processo para a preparacao de novos compostos derivados da acetamina e de composicoes farmaceuticas que os contem
PT87115A (pt) Processo para a preparacao de derivados da dihidropiridazinona e de composicoes farmaceuticas que os contem
PT92264A (pt) Processo para a preparacao de 14alfa, 17alfa-etano-estratrienos e de composicoes farmaceuticas que os contem
PT87090A (pt) Processo para a preparacao de derivados de imidazopiridinas e de composicoes farmaceuticas que os contem
PT95547A (pt) Processo para a preparacao de novos inibidores de alfa-glucosidase e de composicoes farmaceuticas que os contem
PT89501B (pt) Processo para a preparacao de novos gliceridos de amino-acidos e de composicoes farmaceuticas que os contem
PT98697A (pt) Processo para a preparacao de compostos macrociclicos e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960829